Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 17Multiple Myeloma 12Ovarian Neoplasms 9Recurrence 8Lymphoma, B-Cell 8Pancreatic Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma 7Hodgkin Disease 7Burkitt Lymphoma 7Colorectal Neoplasms 6Myeloproliferative Disorders 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Biphenotypic, Acute 5Stomach Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia 4Hematologic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Urogenital Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Osteosarcoma 3Melanoma 3Lymphoma, Follicular 3Leukemia, B-Cell 3

Interventions

Cyclophosphamide 3fludarabine 2Paclitaxel 2Carboplatin 2Bevacizumab 2trastuzumab deruxtecan 1pembrolizumab 1olaparib 1niraparib 1mirvetuximab soravtansine 1irinotecan sucrosofate 1fludarabine phosphate 1denileukin diftitox 1Tinzaparin 1Propranolol 1Palliative Care 1Nivolumab 1Neoadjuvant Therapy 1Music Therapy 1Losartan 1Indocyanine Green 1GEN-1 1Etodolac 1E7777 fusion protein 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × fludarabine × 30 days × Clear all
NCT06305299 2026-05-19

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

NCT07589543 2026-05-15

EB-DUALNK-OV

Beijing Biotech

Phase 1/2 Recruiting
42 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡